MDSL
DHR icon

M.D. Sass LLC’s Danaher DHR Stock Holding History

M.D. Sass LLC’s Portfolio DHR Stock Details DHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.99M Sell
41,926
-159,275
-79% -$28.9M 0.52% 28
2026
Q1 		$38.1M Sell
201,201
-103,818
-34% -$22.1M 2.89% 19
2025
Q4 		$69.8M Sell
305,019
-60,370
-17% -$13.3M 5.5% 6
2025
Q3 		$72.4M Buy
365,389
+8,735
+2% +$1.74M 5.9% 3
2025
Q2 		$70.5M Buy
356,654
+43,333
+14% +$8.4M 5.67% 5
2025
Q1 		$64.2M Buy
313,321
+157,334
+101% +$34.4M 5.65% 5
2024
Q4 		$35.8M Sell
155,987
-20,261
-11% -$4.98M 2.69% 20
2024
Q3 		$49M Sell
176,248
-23,430
-12% -$6.2M 3.63% 15
2024
Q2 		$49.9M Buy
199,678
+76,225
+62% +$19.3M 3.58% 13
2024
Q1 		$30.8M Sell
123,453
-9,863
-7% -$2.41M 3.48% 13
2023
Q4 		$30.8M Buy
133,316
+33,103
+33% +$7.05M 3.71% 14
2023
Q3 		$22M Buy
+100,213
New +$22.4M 2.96% 17

Other funds holding DHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

M.D. Sass LLC's DHR Position: Q2 2026 in Review

M.D. Sass LLC reduced its Danaher (DHR) stake by 79% in Q2 2026, selling an estimated $28.9M and leaving 41,926 shares worth $7.99M. The position accounts for 0.52% of the portfolio, ranked #28.

M.D. Sass LLC first reported a position in DHR in Q3 2023 and has held it in 12 quarters since. The position peaked at $72.4M in Q3 2025. 2,108 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • M.D. Sass LLC held 41,926 shares of Danaher worth $7.99M as of Q2 2026.
  • M.D. Sass LLC sold 159,275 Danaher shares in Q2 2026, an estimated $28.9M.
  • Danaher made up 0.52% of M.D. Sass LLC's portfolio in Q2 2026, its #28 holding.
  • M.D. Sass LLC first reported a position in Danaher in Q3 2023 and has held it in 12 quarters since.
  • M.D. Sass LLC's Danaher position peaked at $72.4M in Q3 2025.
  • 2,108 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.